Soleno Therapeutics Statistics
Total Valuation
SLNO has a market cap or net worth of $2.72 billion. The enterprise value is $2.27 billion.
Important Dates
The next estimated earnings date is Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SLNO has 51.72 million shares outstanding. The number of shares has increased by 30.39% in one year.
| Current Share Class | 51.72M |
| Shares Outstanding | 51.72M |
| Shares Change (YoY) | +30.39% |
| Shares Change (QoQ) | -1.08% |
| Owned by Insiders (%) | 1.61% |
| Owned by Institutions (%) | 122.51% |
| Float | 47.99M |
Valuation Ratios
The trailing PE ratio is 134.95 and the forward PE ratio is 13.33.
| PE Ratio | 134.95 |
| Forward PE | 13.33 |
| PS Ratio | 14.30 |
| Forward PS | 5.67 |
| PB Ratio | 6.11 |
| P/TBV Ratio | 6.11 |
| P/FCF Ratio | 58.25 |
| P/OCF Ratio | 58.16 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 133.69, with an EV/FCF ratio of 48.55.
| EV / Earnings | 110.79 |
| EV / Sales | 11.91 |
| EV / EBITDA | 133.69 |
| EV / EBIT | 151.73 |
| EV / FCF | 48.55 |
Financial Position
The company has a current ratio of 5.80, with a Debt / Equity ratio of 0.12.
| Current Ratio | 5.80 |
| Quick Ratio | 5.44 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 2.93 |
| Debt / FCF | 1.12 |
| Interest Coverage | 2.73 |
Financial Efficiency
Return on equity (ROE) is 6.01% and return on invested capital (ROIC) is 2.33%.
| Return on Equity (ROE) | 6.01% |
| Return on Assets (ROA) | 2.09% |
| Return on Invested Capital (ROIC) | 2.33% |
| Return on Capital Employed (ROCE) | 2.98% |
| Weighted Average Cost of Capital (WACC) | -10.81% |
| Revenue Per Employee | $1.05M |
| Profits Per Employee | $112,500 |
| Employee Count | 182 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.82% in the last 52 weeks. The beta is -2.80, so SLNO's price volatility has been lower than the market average.
| Beta (5Y) | -2.80 |
| 52-Week Price Change | -16.82% |
| 50-Day Moving Average | 38.96 |
| 200-Day Moving Average | 56.61 |
| Relative Strength Index (RSI) | 77.92 |
| Average Volume (20 Days) | 6,440,947 |
Short Selling Information
The latest short interest is 8.45 million, so 16.34% of the outstanding shares have been sold short.
| Short Interest | 8.45M |
| Short Previous Month | 9.33M |
| Short % of Shares Out | 16.34% |
| Short % of Float | 17.61% |
| Short Ratio (days to cover) | 5.81 |
Income Statement
In the last 12 months, SLNO had revenue of $190.41 million and earned $20.48 million in profits. Earnings per share was $0.39.
| Revenue | 190.41M |
| Gross Profit | 187.71M |
| Operating Income | 14.95M |
| Pretax Income | 20.89M |
| Net Income | 20.48M |
| EBITDA | 16.97M |
| EBIT | 14.95M |
| Earnings Per Share (EPS) | $0.39 |
Full Income StatementBalance Sheet
The company has $305.47 million in cash and $52.55 million in debt, with a net cash position of $453.54 million or $8.77 per share.
| Cash & Cash Equivalents | 305.47M |
| Total Debt | 52.55M |
| Net Cash | 453.54M |
| Net Cash Per Share | $8.77 |
| Equity (Book Value) | 450.12M |
| Book Value Per Share | 8.61 |
| Working Capital | 294.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $46.80 million and capital expenditures -$73,000, giving a free cash flow of $46.73 million.
| Operating Cash Flow | 46.80M |
| Capital Expenditures | -73,000 |
| Depreciation & Amortization | 2.02M |
| Net Borrowing | n/a |
| Free Cash Flow | 46.73M |
| FCF Per Share | $0.90 |
Full Cash Flow StatementMargins
Gross margin is 98.58%, with operating and profit margins of 7.85% and 10.97%.
| Gross Margin | 98.58% |
| Operating Margin | 7.85% |
| Pretax Margin | 10.97% |
| Profit Margin | 10.97% |
| EBITDA Margin | 8.91% |
| EBIT Margin | 7.85% |
| FCF Margin | 24.54% |
Dividends & Yields
SLNO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.39% |
| Shareholder Yield | -30.39% |
| Earnings Yield | 0.75% |
| FCF Yield | 1.72% |
Analyst Forecast
The average price target for SLNO is $90.13, which is 71.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $90.13 |
| Price Target Difference | 71.48% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Aug 26, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
SLNO has an Altman Z-Score of 16.78 and a Piotroski F-Score of 4.
| Altman Z-Score | 16.78 |
| Piotroski F-Score | 4 |
